Apoptosis-modulating proteins
US6586395B1 · kind B1 · utility
5Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 6, 1995 |
| Grant date | Jul 1, 2003 |
| Priority date | — |
| Expiry date | Jun 6, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel peptides and compositions capable of modulating apoptosis in cells, and to methods of modulating apoptosis employing the novel peptides and compositions of the invention. In one aspect, the invention is directed to novel homologs of bcl-2 designated CDN-1, CDN-2, and CDN-3, and fragments, variants, homologs and derivatives thereof, which are capable of modulating apoptosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.